Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development

Hepatic Osteodystrophy—Molecular Mechanisms Proposed to Favor Its Development

Almost all patients with chronic liver diseases (CLD) show altered bone metabolism. Depending on the etiology, this manifests in a severe osteoporosis in up to 75% of the affected patients. Due to high prevalence, the generic term hepatic osteodystrophy (HOD) evolved, describing altered bone metabol...

Full description

Bibliographic Details
Main Authors:	Sabrina Ehnert, Romina H. Aspera-Werz, Marc Ruoß, Steven Dooley, Jan G. Hengstler, Silvio Nadalin, Borna Relja, Andreas Badke, Andreas K. Nussler
Format:	Article
Language:	English
Published:	MDPI AG 2019-05-01
Series:	International Journal of Molecular Sciences
Subjects:	bone metabolism osteopenia osteoporosis liver disease hepatic osteodystrophy vitamin D metabolism transforming growth factor beta (TGF-β) bone morphogenetic proteins (BMPs) histone deacetylases (HDACs) sclerostin
Online Access:	https://www.mdpi.com/1422-0067/20/10/2555

Similar Items

Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease
by: Yogesh Karoli, et al.
Published: (2016-08-01)

Romosozumab: A new anabolic arrow in quiver for management of osteoporosis
by: Alok Singh, et al.
Published: (2020-01-01)

Auswirkungen von Gewichtsreduktion und einem kontrollierten Trainingsprogramm auf die Serumkonzentration der Bone morphogenetic proteins (BMPs) -2 und -4 bei Patienten mit Typ 2 Diabetes
by: Böhler, Nina
Published: (2014)

Bone Regeneration Using Bone Morphogenetic Proteins and Various Biomaterial Carriers
by: Zeeshan Sheikh, et al.
Published: (2015-04-01)

THE SPECTRUM OF RENAL OSTEODYSTROPHY – NOVEL AND OLD PARADIGMS
by: Violeta Bojinca, et al.
Published: (2016-03-01)

The Evaluation of Renal Osteodystrophy in Patients on Hemodialysis by Biochemical and Radiological Methods
by: Sibel Mandıroğlu, et al.
Published: (2013-04-01)

Investigation of renal osteodystrophy among hemodialysis patients referring to Towhid Hospital, Sanandaj, Iran
by: Vahid Sedighi-Gourabi, et al.
Published: (2013-10-01)

Osteoporosis and FRAX risk in patients with liver cirrhosis
by: Azucena I. Casanova-Lara, et al.
Published: (2014-10-01)

Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment
by: Adriano L. Spirlandeli, et al.

Raman Spectroscopic and Microscopic Analysis for Monitoring Renal Osteodystrophy Signatures
by: John D. Ciubuc, et al.
Published: (2018-04-01)

Sclerostin Blood Levels Before and After Kidney Transplantation
by: Marco Bonani, et al.
Published: (2014-07-01)

Bone marrow adiposity inversely correlates with bone turnover in pediatric renal osteodystrophy
by: Ornatcha Sirimongkolchaiyakul, et al.
Published: (2021-12-01)

Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease
by: A.T.A. Taveira, et al.
Published: (2010-11-01)

Hepatic Osteodystrophy: A Global (Re)View of the Problem
by: Mihai Lazăr, et al.
Published: (2017-01-01)

Prevalence and Pattern of Renal Osteodystrophy in Chronic Hemodialysis Patients: A Cross Sectional Study of 103 Patients
by: Buargub Mahdia, et al.
Published: (2006-01-01)

Metabolic bone disease of prematurity
by: Stacy E. Rustico, MD, et al.
Published: (2014-09-01)

Renal osteodystrophy presenting predominantly with osteosclerosis
by: Oriazo Theophilus Akhigbe, et al.
Published: (2015-01-01)

Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease
by: Fangli Zhou, et al.
Published: (2021-08-01)

Serum sclerostin is negatively associated with insulin sensitivity in obese but not lean women
by: Anouar Aznou, et al.
Published: (2021-03-01)

Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy
by: Irma Machuca-Gayet, et al.
Published: (2020-04-01)

Mineral and bone disorders secondary to chronic kidney disease (renal osteodystrophy)
by: Alphonsus N. Onyiriuka, et al.
Published: (2015-02-01)

Renal Osteodystrophy
by: Aynur Metin Terzibaşoğlu, et al.
Published: (2004-12-01)

Mineral and Bone Disorders After Kidney Transplantation
by: Chandan Vangala, et al.
Published: (2018-07-01)

Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: A preliminary study
by: Stacy E. Rustico, et al.
Published: (2015-03-01)

Evaluation of renal osteodystrophy in patients under hemodialysis treatment using digital radiography
by: Talaeipour AR, et al.
Published: (2001-09-01)

The association of circulating sclerostin level with markers of bone metabolism in patients with thyroid dysfunction
by: Mihaljević Olgica, et al.
Published: (2020-01-01)

The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings
by: Maria Eugênia Leite Duarte, et al.

Smoking Dependent Alterations in Bone Formation and Inflammation Represent Major Risk Factors for Complications Following Total Joint Arthroplasty
by: Sabrina Ehnert, et al.
Published: (2019-03-01)

From the Clinical Problem to the Basic Research—Co-Culture Models of Osteoblasts and Osteoclasts
by: Sheng Zhu, et al.
Published: (2018-08-01)

Feasibility of Cell Lines for In Vitro Co-Cultures Models for Bone Metabolism
by: Sabrina Ehnert, et al.
Published: (2020-09-01)

Caffeine is a risk factor for osteopenia of prematurity in preterm infants: a cohort study
by: Ebtihal Ali, et al.
Published: (2018-01-01)

Sclerostin Modulation Holds Promise for Dental Indications
by: Mohamed G. Hassan, et al.
Published: (2018-11-01)

Effects of Fish Bone Meal Flour and Mineral Water «Abalakhskaya» on Bone Mineral Density
by: A.M. Palshina, et al.
Published: (2018-03-01)

The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up
by: Adam Kern, et al.
Published: (2021-03-01)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
by: Saikat Dewanjee, et al.
Published: (2021-05-01)

Cigarette Smoke Induces the Risk of Metabolic Bone Diseases: Transforming Growth Factor Beta Signaling Impairment via Dysfunctional Primary Cilia Affects Migration, Proliferation, and Differentiation of Human Mesenchymal Stem Cells
by: Romina H. Aspera-Werz, et al.
Published: (2019-06-01)

Hepatic osteodystrophy and fracture risk prediction using FRAX tool in Indian patients with cirrhosis
by: Arka De, et al.
Published: (2020-10-01)

Role of Citrate in Pathophysiology and Medical Management of Bone Diseases
by: Donatella Granchi, et al.
Published: (2019-10-01)

3D Environment Is Required in Vitro to Demonstrate Altered Bone Metabolism Characteristic for Type 2 Diabetics
by: Victor Häussling, et al.
Published: (2021-03-01)

Albright Hereditary Osteodystrophy: A Case Report
by: Deepa Hugar, et al.
Published: (2014-10-01)